We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

COG.GB Cambridge Cognition Holdings PLC

0.00 (0.00%)
24 May 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings PLC AQSE:COG.GB Aquis Stock Exchange Ordinary Share GB00B8DV9647
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 45.50 42.00 49.00 45.50 45.50 45.50 0.00 07:01:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cambridge Cognition Holdings PLC Issue of Warrants (8898O)

05/10/2023 5:33pm

UK Regulatory

Cambridge Cognition (AQSE:COG.GB)
Historical Stock Chart

From May 2023 to May 2024

Click Here for more Cambridge Cognition Charts.


RNS Number : 8898O

Cambridge Cognition Holdings PLC

05 October 2023

5 October 2023

Cambridge Cognition Holdings Plc

("Cambridge Cognition", the "Group" or the "Company")

Issue of Warrants

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces, further to the Company's announcement on 26 September 2023, that the Company has issued Claret European Specialty Lending Company III, S.à r.l. ("Claret") with warrants to subscribe for 722,565 new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 74.734p.


Cambridge Cognition Holdings Plc              Tel: 012 2381 0700 
 Matthew Stork, Chief Executive Officer 
 Stephen Symonds, Chief Financial Officer 
Panmure Gordon (UK) Limited (NOMAD and Joint  Tel: 020 7886 2500 
 Broker)                                       (Corporate Finance) 
 Freddy Crossley / Emma Earl / Mark Rodgers    (Corporate Broking) 
 Rupert Dearden 
Dowgate Capital Limited (Joint Broker)        Tel: 020 3903 7715 
 David Poutney / James Serjeant 
IFC Advisory Ltd (Financial PR and IR)        Tel: 020 3934 6630 
 Tim Metcalfe / Graham Herring / Zach Cohen 

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

October 05, 2023 12:33 ET (16:33 GMT)

1 Year Cambridge Cognition Chart

1 Year Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

Your Recent History

Delayed Upgrade Clock